TAYLOR SIMON: Open Payments
NPI 1457085979 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 21 payments from 13 companies in 2025. Trend: 2023 $1,889 · 2024 $2,443 · 2025 $757
Food & beverage: $714Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $268 |
| Daiichi Sankyo Inc. | 2 | $132 |
| ABBVIE INC. | 2 | $56 |
| JAZZ PHARMACEUTICALS INC. | 2 | $49 |
| Telix Pharmaceuticals | 1 | $39 |
| Genmab U.S., Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $28 |
| Incyte Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: ENHERTU, DATROWAY, EPKINLY, ZIIHERA, ILLUCCIX, FRUZAQLA, VERZENIO, JAKAFI.
Industry payments across CA — which companies pay providers there.
